The immunoglobulin heavy locus (IGH) on chromosome 14 is the genomic region encoding immunoglobulin heavy chains, fundamental components of antibody production and B cell development. Functionally, IGH undergoes V(D)J recombination during B cell development, with heavy chain variable segment (VH) replacement providing a secondary RAG-mediated recombination mechanism to alter preformed IgH genes in both mice and humans 1. The locus contains approximately 30 kb of complex 3' regulatory regions with multiple enhancers that control rearrangements 2, though these regulatory elements show limited sequence conservation between rodents and primates while maintaining conserved structural features including palindromes and repetitive elements. Clinically, IGH translocations are pathologically significant. The t(11;14)(CCND1;IGH) translocation in multiple myeloma remains the only subset sensitive to venetoclax therapy, though resistance mechanisms involve RAS pathway mutations and genomic selection events in BCL2/MCL1 pathways 3. In follicular lymphoma, bcl-2/IgH translocations are negatively correlated with disease stage, with combined FISH and PCR-GeneScan detection improving diagnostic sensitivity 4. IGH gene rearrangement analysis aids diagnosis in hematologic malignancies including Hodgkin's disease 5. Conversely, IGH locus studies found no association with human narcolepsy despite canine linkage 6. The locus also contains processed pseudogenes, including elk-1 pseudogenes inserted approximately 30-60 million years ago 7.